. AAVrh.10 delivery of novel APOE2-Christchurch variant suppresses amyloid and Tau pathology in Alzheimer's disease mice. Mol Ther. 2024 Dec 4;32(12):4303-4318. Epub 2024 Nov 6 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

Therapeutics

  1. LX1001

Mutations

  1. APOE R154S (Christchurch)

News

  1. Beyond Antibodies: From CTAD, New Attempts at Outflanking Alzheimer’s